Výsledky vyhledávání - "George I. Moonsammy"

Immunization Of Us Soldiers With A Two-Dose Primary Series Of Inactivated Hepatitis A Vaccine: Early Immune Response, Persistence Of Antibody, And Response To A Third Dose At 1 Year

Autor: Andrée Delem, Leonard N. Binn, Robert F. DeFraites, Charles H. Hoke, David S. Krause, Brian H. Feighner, Philip Macarthy, Devesh D. Kanjarpane, George I. Moonsammy, Margot R. Krauss

Publikováno v: Journal of Infectious Diseases. 171:S61-S69

To study the feasibility of using inactivated hepatitis A vaccine for rapid immunization of US soldiers, 276 randomized seronegative volunteers received one of four regimens: two injections, on day 0 or one each on day 0 and 14, day 0 and 30, or day

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9879e0c74026a9a88c87c1277f64e7c6
https://doi.org/10.1093/infdis/171.supplement_1.s61

Zobrazit plný text záznamu

Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another☆

Autor: Larry M. Bush, Jerome A. Boscia, George I. Moonsammy

Publikováno v: Vaccine. 9:807-809

The purpose of this study was to determine if a hepatitis B vaccination schedule initiated with one recombinant DNA vaccine could be completed with another. Forty-eight adults on a hepatitis B vaccination schedule of 0, 1 and 6 months had received th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ea80601571d398e3c88fd1c209dfb2
https://doi.org/10.1016/0264-410x(91)90217-t

Zobrazit plný text záznamu

Orally active and potent inhibitors of gamma-aminobutyric acid uptake

Autor: Fadia E. Ali, William E. Bondinell, Penelope A. Dandridge, James S. Frazee, Eleanor Garvey, Gerald R. Girard, Carl Kaiser, Thomas W. Ku, John J. Lafferty, George I. Moonsammy, Hye-Ja Oh, Julia A. Rush, Paulette E. Setler, Orum D. Stringer, Joseph W. Venslavsky, Beth W. Volpe, Libby M. Yunger, Charles L. Zirkle

Publikováno v: Journal of medicinal chemistry. 28(5)

3-Pyrrolidineacetic acid (1a), certain piperidinecarboxylic acids--i.e., 3-piperidinecarboxylic acid (2a), 1,2,5,6-tetrahydro-3-pyridinecarboxylic acid (3a), and cis-4-hydroxy-3-piperidinecarboxylic acid (4a)--cis-3-aminocyclohexanecarboxylic acid (5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f28e454b6d1c3bd12b9d0bafecae0c
https://pubmed.ncbi.nlm.nih.gov/2985785

Zobrazit plný text záznamu

Factors influencing patient evaluability in anti-infective clinical trials

Autor: George I. Moonsammy, Jean A. Hosutt, Sean A. Reade, Joseph T. McDevitt, Barbara T. Nagle

Publikováno v: Controlled Clinical Trials. 7:251

of patients were evaluable. Primary reasons for non-evaluability in therapeutic protocols included insufficient evidence of infection (28%), resistant organisms (3), insufficient course of therapy (2$), and underlying disease or complicating factors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055f63114eae62f2edf3156cedff666c
https://doi.org/10.1016/0197-2456(86)90121-2

Zobrazit plný text záznamu